Global Epilepsy Diagnosis & Treatment Market Size, Status and Forecast 2021-2027

てんかん診断・治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Epilepsy Diagnosis & Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR2232
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:96
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥858,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、てんかん診断・治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(診断(神経学的検査、血液検査、画像診断)、治療(医療、外科))、用途別市場規模(病院、クリニック)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・てんかん診断・治療の市場動向
・企業の競争状況、市場シェア
・てんかん診断・治療の種類別市場規模(診断(神経学的検査、血液検査、画像診断)、治療(医療、外科))
・てんかん診断・治療の用途別市場規模(病院、クリニック)
・てんかん診断・治療の北米市場規模2016-2027(アメリカ、カナダ)
・てんかん診断・治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・てんかん診断・治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・てんかん診断・治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・てんかん診断・治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Pfizer、Johnson & Johnson、UCB Pharma、Abbott、GlaxoSmithKline、Novartis、Sanofi、Takeda、Medtronic、Natus Medical、Siemens)
・結論

Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the arms and legs, and others are some of the common symptoms of the disease.
Increasing prevalence of epilepsy is a major driver for the market. According to a report by the World Health Organization (2018), about 50 million people across the world are estimated to suffer from epilepsy, making it one of the most common neurological diseases. In addition, the report states that the total number of people aged 65 or more is projected to increase from 524 million in 2010 to approximately 1.5 billion by 2050.

Market Analysis and Insights: Global Epilepsy Diagnosis & Treatment Market
The global Epilepsy Diagnosis & Treatment market size is projected to reach US$ 21010 million by 2026, from US$ 7778.7 million in 2019, at a CAGR of 15.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epilepsy Diagnosis & Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epilepsy Diagnosis & Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epilepsy Diagnosis & Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epilepsy Diagnosis & Treatment market.

Global Epilepsy Diagnosis & Treatment Scope and Market Size
Epilepsy Diagnosis & Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy Diagnosis & Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diagnosis (Neurological Exam, Blood Test, Imaging)
Treatment (Medication, Surgery)

Segment by Application
Hospitals
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Johnson & Johnson
UCB Pharma
Abbott
GlaxoSmithKline
Novartis
Sanofi
Takeda
Medtronic

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epilepsy Diagnosis & Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis (Neurological Exam, Blood Test, Imaging)
1.2.3 Treatment (Medication, Surgery)
1.3 Market by Application
1.3.1 Global Epilepsy Diagnosis & Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epilepsy Diagnosis & Treatment Market Perspective (2016-2027)
2.2 Epilepsy Diagnosis & Treatment Growth Trends by Regions
2.2.1 Epilepsy Diagnosis & Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epilepsy Diagnosis & Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Epilepsy Diagnosis & Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Epilepsy Diagnosis & Treatment Industry Dynamic
2.3.1 Epilepsy Diagnosis & Treatment Market Trends
2.3.2 Epilepsy Diagnosis & Treatment Market Drivers
2.3.3 Epilepsy Diagnosis & Treatment Market Challenges
2.3.4 Epilepsy Diagnosis & Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epilepsy Diagnosis & Treatment Players by Revenue
3.1.1 Global Top Epilepsy Diagnosis & Treatment Players by Revenue (2016-2021)
3.1.2 Global Epilepsy Diagnosis & Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Epilepsy Diagnosis & Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epilepsy Diagnosis & Treatment Revenue
3.4 Global Epilepsy Diagnosis & Treatment Market Concentration Ratio
3.4.1 Global Epilepsy Diagnosis & Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Diagnosis & Treatment Revenue in 2020
3.5 Epilepsy Diagnosis & Treatment Key Players Head office and Area Served
3.6 Key Players Epilepsy Diagnosis & Treatment Product Solution and Service
3.7 Date of Enter into Epilepsy Diagnosis & Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epilepsy Diagnosis & Treatment Breakdown Data by Type
4.1 Global Epilepsy Diagnosis & Treatment Historic Market Size by Type (2016-2021)
4.2 Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Type (2022-2027)

5 Epilepsy Diagnosis & Treatment Breakdown Data by Application
5.1 Global Epilepsy Diagnosis & Treatment Historic Market Size by Application (2016-2021)
5.2 Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epilepsy Diagnosis & Treatment Market Size (2016-2027)
6.2 North America Epilepsy Diagnosis & Treatment Market Size by Type
6.2.1 North America Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021)
6.2.2 North America Epilepsy Diagnosis & Treatment Market Size by Type (2022-2027)
6.2.3 North America Epilepsy Diagnosis & Treatment Market Size by Type (2016-2027)
6.3 North America Epilepsy Diagnosis & Treatment Market Size by Application
6.3.1 North America Epilepsy Diagnosis & Treatment Market Size by Application (2016-2021)
6.3.2 North America Epilepsy Diagnosis & Treatment Market Size by Application (2022-2027)
6.3.3 North America Epilepsy Diagnosis & Treatment Market Size by Application (2016-2027)
6.4 North America Epilepsy Diagnosis & Treatment Market Size by Country
6.4.1 North America Epilepsy Diagnosis & Treatment Market Size by Country (2016-2021)
6.4.2 North America Epilepsy Diagnosis & Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Epilepsy Diagnosis & Treatment Market Size (2016-2027)
7.2 Europe Epilepsy Diagnosis & Treatment Market Size by Type
7.2.1 Europe Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021)
7.2.2 Europe Epilepsy Diagnosis & Treatment Market Size by Type (2022-2027)
7.2.3 Europe Epilepsy Diagnosis & Treatment Market Size by Type (2016-2027)
7.3 Europe Epilepsy Diagnosis & Treatment Market Size by Application
7.3.1 Europe Epilepsy Diagnosis & Treatment Market Size by Application (2016-2021)
7.3.2 Europe Epilepsy Diagnosis & Treatment Market Size by Application (2022-2027)
7.3.3 Europe Epilepsy Diagnosis & Treatment Market Size by Application (2016-2027)
7.4 Europe Epilepsy Diagnosis & Treatment Market Size by Country
7.4.1 Europe Epilepsy Diagnosis & Treatment Market Size by Country (2016-2021)
7.4.2 Europe Epilepsy Diagnosis & Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size (2016-2027)
8.2 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Type
8.2.1 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Application
8.3.1 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Region
8.4.1 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epilepsy Diagnosis & Treatment Market Size (2016-2027)
9.2 Latin America Epilepsy Diagnosis & Treatment Market Size by Type
9.2.1 Latin America Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Epilepsy Diagnosis & Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Epilepsy Diagnosis & Treatment Market Size by Type (2016-2027)
9.3 Latin America Epilepsy Diagnosis & Treatment Market Size by Application
9.3.1 Latin America Epilepsy Diagnosis & Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Epilepsy Diagnosis & Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Epilepsy Diagnosis & Treatment Market Size by Application (2016-2027)
9.4 Latin America Epilepsy Diagnosis & Treatment Market Size by Country
9.4.1 Latin America Epilepsy Diagnosis & Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Epilepsy Diagnosis & Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size (2016-2027)
10.2 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Type
10.2.1 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Application
10.3.1 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Country
10.4.1 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Epilepsy Diagnosis & Treatment Introduction
11.1.4 Pfizer Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Epilepsy Diagnosis & Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 UCB Pharma
11.3.1 UCB Pharma Company Details
11.3.2 UCB Pharma Business Overview
11.3.3 UCB Pharma Epilepsy Diagnosis & Treatment Introduction
11.3.4 UCB Pharma Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.3.5 UCB Pharma Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Epilepsy Diagnosis & Treatment Introduction
11.4.4 Abbott Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Epilepsy Diagnosis & Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Epilepsy Diagnosis & Treatment Introduction
11.6.4 Novartis Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Epilepsy Diagnosis & Treatment Introduction
11.7.4 Sanofi Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Epilepsy Diagnosis & Treatment Introduction
11.8.4 Takeda Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.8.5 Takeda Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Epilepsy Diagnosis & Treatment Introduction
11.9.4 Medtronic Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.9.5 Medtronic Recent Development
11.10 Natus Medical
11.10.1 Natus Medical Company Details
11.10.2 Natus Medical Business Overview
11.10.3 Natus Medical Epilepsy Diagnosis & Treatment Introduction
11.10.4 Natus Medical Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.10.5 Natus Medical Recent Development
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens Epilepsy Diagnosis & Treatment Introduction
11.11.4 Siemens Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021)
11.11.5 Siemens Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epilepsy Diagnosis & Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnosis (Neurological Exam, Blood Test, Imaging)
Table 3. Key Players of Treatment (Medication, Surgery)
Table 4. Global Epilepsy Diagnosis & Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Epilepsy Diagnosis & Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Epilepsy Diagnosis & Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Epilepsy Diagnosis & Treatment Market Share by Regions (2016-2021)
Table 8. Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Epilepsy Diagnosis & Treatment Market Share by Regions (2022-2027)
Table 10. Epilepsy Diagnosis & Treatment Market Trends
Table 11. Epilepsy Diagnosis & Treatment Market Drivers
Table 12. Epilepsy Diagnosis & Treatment Market Challenges
Table 13. Epilepsy Diagnosis & Treatment Market Restraints
Table 14. Global Epilepsy Diagnosis & Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Epilepsy Diagnosis & Treatment Market Share by Players (2016-2021)
Table 16. Global Top Epilepsy Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy Diagnosis & Treatment as of 2020)
Table 17. Ranking of Global Top Epilepsy Diagnosis & Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Epilepsy Diagnosis & Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Epilepsy Diagnosis & Treatment Product Solution and Service
Table 21. Date of Enter into Epilepsy Diagnosis & Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Epilepsy Diagnosis & Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Epilepsy Diagnosis & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Epilepsy Diagnosis & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Epilepsy Diagnosis & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Epilepsy Diagnosis & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Epilepsy Diagnosis & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Epilepsy Diagnosis & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Epilepsy Diagnosis & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Epilepsy Diagnosis & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Epilepsy Diagnosis & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Epilepsy Diagnosis & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Epilepsy Diagnosis & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Epilepsy Diagnosis & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Epilepsy Diagnosis & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Epilepsy Diagnosis & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Epilepsy Diagnosis & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Epilepsy Diagnosis & Treatment Product
Table 64. Pfizer Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Epilepsy Diagnosis & Treatment Product
Table 69. Johnson & Johnson Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. UCB Pharma Company Details
Table 72. UCB Pharma Business Overview
Table 73. UCB Pharma Epilepsy Diagnosis & Treatment Product
Table 74. UCB Pharma Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 75. UCB Pharma Recent Development
Table 76. Abbott Company Details
Table 77. Abbott Business Overview
Table 78. Abbott Epilepsy Diagnosis & Treatment Product
Table 79. Abbott Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 80. Abbott Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Epilepsy Diagnosis & Treatment Product
Table 84. GlaxoSmithKline Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Epilepsy Diagnosis & Treatment Product
Table 89. Novartis Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Epilepsy Diagnosis & Treatment Product
Table 94. Sanofi Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Takeda Company Details
Table 97. Takeda Business Overview
Table 98. Takeda Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 99. Takeda Recent Development
Table 100. Medtronic Company Details
Table 101. Medtronic Business Overview
Table 102. Medtronic Epilepsy Diagnosis & Treatment Product
Table 103. Medtronic Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 104. Medtronic Recent Development
Table 105. Natus Medical Company Details
Table 106. Natus Medical Business Overview
Table 107. Natus Medical Epilepsy Diagnosis & Treatment Product
Table 108. Natus Medical Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 109. Natus Medical Recent Development
Table 110. Siemens Company Details
Table 111. Siemens Business Overview
Table 112. Siemens Epilepsy Diagnosis & Treatment Product
Table 113. Siemens Revenue in Epilepsy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 114. Siemens Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epilepsy Diagnosis & Treatment Market Share by Type: 2020 VS 2027
Figure 2. Diagnosis (Neurological Exam, Blood Test, Imaging) Features
Figure 3. Treatment (Medication, Surgery) Features
Figure 4. Global Epilepsy Diagnosis & Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Epilepsy Diagnosis & Treatment Report Years Considered
Figure 8. Global Epilepsy Diagnosis & Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Epilepsy Diagnosis & Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Epilepsy Diagnosis & Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Epilepsy Diagnosis & Treatment Market Share by Regions (2022-2027)
Figure 12. Global Epilepsy Diagnosis & Treatment Market Share by Players in 2020
Figure 13. Global Top Epilepsy Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy Diagnosis & Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Epilepsy Diagnosis & Treatment Revenue in 2020
Figure 15. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Epilepsy Diagnosis & Treatment Market Share by Type (2016-2027)
Figure 19. North America Epilepsy Diagnosis & Treatment Market Share by Application (2016-2027)
Figure 20. North America Epilepsy Diagnosis & Treatment Market Share by Country (2016-2027)
Figure 21. United States Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Epilepsy Diagnosis & Treatment Market Share by Type (2016-2027)
Figure 25. Europe Epilepsy Diagnosis & Treatment Market Share by Application (2016-2027)
Figure 26. Europe Epilepsy Diagnosis & Treatment Market Share by Country (2016-2027)
Figure 27. Germany Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Epilepsy Diagnosis & Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Epilepsy Diagnosis & Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Epilepsy Diagnosis & Treatment Market Share by Region (2016-2027)
Figure 37. China Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Epilepsy Diagnosis & Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Epilepsy Diagnosis & Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Epilepsy Diagnosis & Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Epilepsy Diagnosis & Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Epilepsy Diagnosis & Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Epilepsy Diagnosis & Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Epilepsy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 57. Johnson & Johnson Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 58. UCB Pharma Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 59. Abbott Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 63. Takeda Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 64. Medtronic Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 65. Natus Medical Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 66. Siemens Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[てんかん診断・治療の世界市場規模・現状・予測2021年-2027年] (Global Epilepsy Diagnosis & Treatment Market Size, Status and Forecast 2021-2027 / QY21APR2232)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆